Anika Therapeutics Inc (ANIK)

Nov 08, 2024

Orthobiologics Market Size, Growth, Opportunities 2024-2032 | - openPR

Nov 08, 2024

Nov 06, 2024

Anika Therapeutics Navigates Geopolitical Risks Amid Global Conflicts - TipRanks

Nov 06, 2024

Nov 05, 2024

Anika Therapeutics, Inc. (NASDAQ:ANIK) Shares Sold by Capital Management Corp VA - MarketBeat

Nov 05, 2024

Nov 05, 2024

Anika Therapeutics Announces Third Quarter Financial ResultsOn October 31, 2024, Anika Therapeutics, Inc. released a press statement unveiling its financial outcomes for the third quarter concluding on September 30, 2024. As per the report - Defense World

Nov 05, 2024

Nov 05, 2024

Viscosupplementation Market Report Analysis, Growth - openPR

Nov 05, 2024

Nov 04, 2024

Anika Therapeutics (NASDAQ:ANIK) Downgraded to Hold Rating by StockNews.com - MarketBeat

Nov 04, 2024

Nov 04, 2024

Anika Therapeutics, Inc. (NASDAQ:ANIK) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 04, 2024

Nov 04, 2024

Barrington Research Cuts Anika Therapeutics (NASDAQ:ANIK) Price Target to $25.00 - Defense World

Nov 04, 2024

Nov 03, 2024

Earnings call: Anika Therapeutics Focuses on HA Products Amid Restructuring By Investing.com - Investing.com South Africa

Nov 03, 2024

Nov 03, 2024

Earnings call: Anika Therapeutics Focuses on HA Products Amid Restructuring - Investing.com

Nov 03, 2024

Nov 02, 2024

Anika Therapeutics Third Quarter 2024 Earnings: Misses Expectations - Simply Wall St

Nov 02, 2024

Nov 02, 2024

Anika Therapeutics (ANIK) Reports Q3 Loss, Lags Revenue Estimates - MSN

Nov 02, 2024

Nov 01, 2024

Anika Therapeutics (NASDAQ:ANIK) Given New $25.00 Price Target at Barrington Research - MarketBeat

Nov 01, 2024

Nov 01, 2024

Anika Therapeutics (NASDAQ:ANIK shareholders incur further losses as stock declines 30% this week, taking five-year losses to 72% - Simply Wall St

Nov 01, 2024

Nov 01, 2024

Anika: Q3 Earnings Snapshot - New Haven Register

Nov 01, 2024

Nov 01, 2024

Anika Therapeutics Inc (ANIK) Q3 2024 Earnings Call Highlights: Strategic Shifts Amid Revenue ... - Yahoo Finance UK

Nov 01, 2024

Nov 01, 2024

Anika Therapeutics Inc (ANIK) Q3 2024 Earnings Call Highlights: Strategic Shifts Amid Revenue Decline - GuruFocus.com

Nov 01, 2024

Nov 01, 2024

Anika Therapeutics divests Arthrosurface, eyes Parcus sale - Investing.com India

Nov 01, 2024

Nov 01, 2024

Anika Therapeutics Focuses on Core Growth Amid Restructuring - TipRanks

Nov 01, 2024

Oct 31, 2024

Anika Reports Third Quarter 2024 Financial Results - GlobeNewswire

Oct 31, 2024

Oct 31, 2024

Anika Therapeutics divests Arthrosurface, eyes Parcus sale By Investing.com - Investing.com Canada

Oct 31, 2024

Oct 31, 2024

Anika Therapeutics stock hits 52-week low at $18.67 - Investing.com

Oct 31, 2024

Oct 31, 2024

ANIKAnika Therapeutics Inc Latest Stock News & Market Updates - StockTitan

Oct 31, 2024

Oct 31, 2024

Phoenix Brio, Incorporated acquired Arthrosurface, Inc. from Anika Therapeutics, Inc. for $10 million. - Marketscreener.com

Oct 31, 2024

Oct 31, 2024

Arthrosurface Returns to it Roots Following Divestiture from Anika Therapeutics - PR Newswire

Oct 31, 2024

Oct 31, 2024

Anika Therapeutics stock hits 52-week low at $18.67 By Investing.com - Investing.com UK

Oct 31, 2024

Oct 31, 2024

Anika Announces Strategic Update of Business with Sale of Arthrosurface and Plan to Divest Parcus Medical - citybiz

Oct 31, 2024

Oct 31, 2024

Anika Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Oct 31, 2024

Oct 31, 2024

Anika Therapeutics Inc (ANIK) Q3 2024: Everything You Need To Kn - GuruFocus.com

Oct 31, 2024

Oct 30, 2024

(ANIK) Proactive Strategies - Stock Traders Daily

Oct 30, 2024

Oct 30, 2024

Investors in Anika Therapeutics (NASDAQ:ANIK) have unfortunately lost 61% over the last five years - Yahoo Finance

Oct 30, 2024

Oct 27, 2024

Anika Therapeutics, Inc. (NASDAQ:ANIK) Sees Significant Decline in Short Interest - MarketBeat

Oct 27, 2024

Oct 25, 2024

Collagen and HA-Based Biomaterials Market Size, Outlook 2031 - openPR

Oct 25, 2024

Oct 24, 2024

Hyaluronic Acid for Osteoarthritis Market Size, Potential - openPR

Oct 24, 2024

Oct 24, 2024

Anika Therapeutics (ANIK) Scheduled to Post Quarterly Earnings on Thursday - MarketBeat

Oct 24, 2024

Oct 24, 2024

Riverwater Partners LLC Has $2.55 Million Position in Anika Therapeutics, Inc. (NASDAQ:ANIK) - MarketBeat

Oct 24, 2024

Oct 22, 2024

Anika Therapeutics (NASDAQ:ANIK) Rating Reiterated by Barrington Research - MarketBeat

Oct 22, 2024

Oct 22, 2024

Combination Treatment In Aesthetics Market Huge Growth - openPR

Oct 22, 2024

Oct 18, 2024

Europe Viscosupplementation Market Detailed In New Research - openPR

Oct 18, 2024

Oct 18, 2024

Anika Announces Third Quarter 2024 Results Conference Call Date - GlobeNewswire

Oct 18, 2024

Oct 17, 2024

Anika Therapeutics, Inc. (NASDAQ:ANIK) Short Interest Update - MarketBeat

Oct 17, 2024

Oct 14, 2024

Knee Hyaluronic Acid Injection Market 2034 Growth Drivers along with Top Players- Sanofi, Anika Therapeutics, Seikagaku, – IndiaPolitics.com - IndiaPolitics.com

Oct 14, 2024